Compiled and authored by Pei Zhengxue

Drug selection for treating hematological indications—February 2, 1994

Chapter 407

### Drug selection for treating hematological indications—February 2, 1994

From Compiled and authored by Pei Zhengxue · Read time 1 min · Updated March 22, 2026

Keywords专著资料, 全文在线浏览, 干扰素在血液病中的应用1995.2.27

Section Index

  1. Drug selection for treating hematological indications—February 2, 1994

Drug selection for treating hematological indications—February 2, 1994

  1. Leukopenia

Psoralea corylifolia, Xian He Cao, Ji Xue Teng, Ku Shen, Huang Qi.

  1. Root treatment for leukemia

Qing Dai, Chan Su. Chan Su is the dried white milky secretion from the parotid glands of amphibians, specifically toads. It has a sweet taste, pungent and warm properties, and is toxic; it enters the stomach and heart meridians, with functions of dispersing swelling, attacking toxins, opening orifices, and relieving pain. Traditionally used to treat boils and sores. It can also be used for vomiting, diarrhea, abdominal pain, and unconsciousness caused by wind-cold invasion of the stomach; take 0.015–0.03 g internally, preferably in pill or powder form. Modern pharmacological research proves that Chan Su has strong cardiotonic, hypertensive, analgesic, anti-tumor, anti-inflammatory, cough-suppressing, expectorant, bronchodilating, and white-blood-cell-raising effects. Given that this product can treat arrhythmias, heart failure, tumors, raise white blood cells, and relieve pain, it is the best choice for treating tumors. Leukemia is a weak link in tumors, and this trial can be used to overcome it. Dosage: take 15–30 mg each time.

Qing Dai is a pigment processing product derived from plants such as Malan in the Acanthaceae family, Polygonum in the Polygonaceae family, and Perilla leaves in the Brassicaceae family; it is also known as indigo, with a salty and cold nature, and has the effects of clearing heat, detoxifying, cooling blood, and eliminating spots. Modern pharmacology: anti-tumor, liver-protecting, antibacterial. For treating chronic myelogenous leukemia, the ratio of Qing Dai to Ming Xiong is 9:1, with certain efficacy. I think that mixing 60 g of Qing Dai with 1 g of Chan Su, grinding them into powder, filling them into capsules of 0.25 g each, producing 244 capsules, taking 2–4 capsules 3 times daily, may yield better results in treating chronic myelogenous leukemia. In this formula, the ratio of Qing Dai to Chan Su is 60:1, with each capsule containing 5 mg of Chan Su; taking 3–6 capsules means ingesting 15–30 mg of Chan Su.

This chapter is prepared for online research and reading; for external materials, please align with original publications and the review process.